A Prospective Multicenter Clinical Investigation Evaluating the Accuracy of the Trimline Design When Treated With SureSmile® Aligners.

NCT ID: NCT07290790

Last Updated: 2025-12-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-12-15

Study Completion Date

2028-02-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a three-armed, multicenter clinical study evaluating the SureSmile clear aligner medical device. The primary objective is to confirm the safety and assess the accuracy of different tooth movements. In addition, the study will investigate and compare three different trimline designs: Scalloped, Straight, and Straight Extended.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Malocclusion

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Extended trimline design

SureSmile® Clear Aligner (Group 3) with extended trimline design (2 mm)

Group Type EXPERIMENTAL

SureSmile® Clear Aligners

Intervention Type DEVICE

SureSmile® Clear Aligners are Custom-made (EU)/patient matched (US) medical devices made to fit appliance with different diameters and lengths to accommodate subjects with different mouth shapes and sizes.

This clinical investigation consists of three different trimline designs groups:

* SureSmile aligner Scallop trimline design
* SureSmile aligner Straight trimline design
* SureSmile aligner Straight extended trimline design

All pre-treatment, treatment, and post-treatment protocols and materials used in all groups are identical, except for the type of trimline design.

Scalloped trimline design

SureSmile® Clear Aligner (Group 1) with scalloped trimline design

Group Type EXPERIMENTAL

SureSmile® Clear Aligners

Intervention Type DEVICE

SureSmile® Clear Aligners are Custom-made (EU)/patient matched (US) medical devices made to fit appliance with different diameters and lengths to accommodate subjects with different mouth shapes and sizes.

This clinical investigation consists of three different trimline designs groups:

* SureSmile aligner Scallop trimline design
* SureSmile aligner Straight trimline design
* SureSmile aligner Straight extended trimline design

All pre-treatment, treatment, and post-treatment protocols and materials used in all groups are identical, except for the type of trimline design.

Straight trimline design

SureSmile® Clear Aligner (Group 2) with straight trimline design

Group Type EXPERIMENTAL

SureSmile® Clear Aligners

Intervention Type DEVICE

SureSmile® Clear Aligners are Custom-made (EU)/patient matched (US) medical devices made to fit appliance with different diameters and lengths to accommodate subjects with different mouth shapes and sizes.

This clinical investigation consists of three different trimline designs groups:

* SureSmile aligner Scallop trimline design
* SureSmile aligner Straight trimline design
* SureSmile aligner Straight extended trimline design

All pre-treatment, treatment, and post-treatment protocols and materials used in all groups are identical, except for the type of trimline design.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SureSmile® Clear Aligners

SureSmile® Clear Aligners are Custom-made (EU)/patient matched (US) medical devices made to fit appliance with different diameters and lengths to accommodate subjects with different mouth shapes and sizes.

This clinical investigation consists of three different trimline designs groups:

* SureSmile aligner Scallop trimline design
* SureSmile aligner Straight trimline design
* SureSmile aligner Straight extended trimline design

All pre-treatment, treatment, and post-treatment protocols and materials used in all groups are identical, except for the type of trimline design.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject willing to participate in the clinical investigation, able to understand the intent risks and benefits of the clinical investigation as well as associated time commitment and follow-ups visits.
* Subject has signed and dated the informed consent form (ICF) .
* Subject aged 18 years or above at time of informed consent.
* Subject has permanent dentition (i.e., all 2nd molars).
* Subject with a dental malocclusion, consistent with Levels 1 and 2 case complexity and within the clinical references as defined in the SureSmile Case Selection Guide.

* Crowding or spacing must be ≤6mm present in one or both arches consistent with level 1 and 2 of case complexity.
* Midline deviation must be ≤3 mm consistent with level 1 and 2 of case complexity.
* Overjet must be ≤4 mm consistent with level 1 and 2 case complexity.
* Overbite must be ≤3 mm consistent with level 1 and 2 case complexity.
* Anterior open bite must be ≤1 mm, consistent with level 1 and 2 case complexity.

Exclusion Criteria

* Subjects unlikely to comply with investigational procedures, or unlikely to come back for follow-up visits, as judged by the Investigator.
* Subject that presents a dental malocclusion classified as level 3 case complexity, as defined in the SureSmile Case Selection Guide.
* Subjects who have completed aligner therapy within the last 12 months or who are in active orthodontic treatment.
* Subjects with active periodontal disease or other unresolved dental conditions such as active cavities, active periodontal disease.
* Subjects with treatment plans requiring transverse correction requiring expansion greater than 4 mm per arch or 2 mm per quadrant, or any skeletal transverse correction.
* Treatment plans requiring sagittal correction exceeding a half-cusp discrepancy (i.e., \>½ unit) in molar or canine relationships.
* Subjects with treatment plans require vertical correction beyond Level 1 and 2 thresholds (i.e., overbite \>3 mm or anterior/posterior open bite \>1 mm), or vertical elastics exceeding 3 mm.
* TMJ (Temporo-Mandibular Join) disorders or history of headaches or migraines.
* Participants with known history of plastic allergies.
* Subjects with presence of skeletal discrepancies necessitating orthognathic surgery, rapid palatal expansion, other orthopedic intervention, unilateral or bilateral cross-bites, mandibular deviations in association with the diagnosed malocclusion
* The use of TADs (Temporary Anchor Devices), plates, other fixed anchorage ancillaries or the use of functional appliances (distalizers, growth modification devices), any approach involving orthopedic or skeletal sagittal correction or the use of hybrid fixed appliances are not considered part of the scope of this clinical investigation and these subjects are not eligible.
* Uncontrolled para-functional habits, e.g., bruxism.
* Any other condition that would make the subject unsuitable for participation, including but not limited to:

* Unstable psychiatric illness.
* Recent myocardial infarction (\< 3 months\*).
* Recent cerebrovascular accident (\< 3 months\*).
* Recent cardiac-valvular prosthesis placement (\< 3 months\*).
* Hemorrhagic diathesis.
* Severe liver dysfunction.
* Known or suspected current malignancy.
* Known pregnancy at the time of enrolment.
* Previous enrolment in the present clinical investigation.
* Involvement in the planning and conduct of the clinical investigation (applies to both Dentsply Sirona personnel and the clinical investigation site).
* Participation in another clinical investigation that may interfere with the present clinical investigation.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Dentsply Sirona Implants and Consumables

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Costanzo Orthodontics

Fresno, California, United States

Site Status

Center for Orthodontic Excellence

Princeton Junction, New Jersey, United States

Site Status

Brush 365 Dental

Frisco, Texas, United States

Site Status

Clinica dental Francesc Batlle

Barcelona, , Spain

Site Status

The Sanford

Bexleyheath, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Spain United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Freja Freedman

Role: CONTACT

Phone: +46 702107415

Email: [email protected]

Ulrika Bonander

Role: CONTACT

Phone: +46 706440844

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Chichetti

Role: primary

Shah

Role: primary

Mahmood

Role: primary

Salman

Role: primary

Shaffie

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

C-OR-25-002

Identifier Type: -

Identifier Source: org_study_id